EU
Emory University’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-26,278
| Closed | -$2.25M | – | 25 |
|
|
2019
Q2 | $2.25M | Buy |
26,278
+902
| +4% | +$77.3K | 1.58% | 24 |
|
|
2019
Q1 | $2.25M | Buy |
25,376
+1,074
| +4% | +$95.4K | 1.58% | 24 |
|
|
2018
Q4 | $2.07M | Sell |
24,302
-2,638
| -10% | -$225K | 1.63% | 20 |
|
|
2018
Q3 | $2.61M | Sell |
26,940
-3,250
| -11% | -$315K | 1.71% | 20 |
|
|
2018
Q2 | $2.84M | Sell |
30,190
-633
| -2% | -$59.6K | 1.89% | 10 |
|
|
2018
Q1 | $2.5M | Buy |
30,823
+8,686
| +39% | +$704K | 1.78% | 21 |
|
|
2017
Q4 | $1.97M | Buy |
22,137
+2,354
| +12% | +$210K | 1.69% | 19 |
|
|
2017
Q3 | $1.84M | Buy |
19,783
+2,453
| +14% | +$228K | 1.46% | 17 |
|
|
2017
Q2 | $1.57M | Sell |
17,330
-6,461
| -27% | -$587K | 1.39% | 36 |
|
|
2017
Q1 | $2.09M | Buy |
23,791
+744
| +3% | +$65.3K | 1.97% | 14 |
|
|
2016
Q4 | $1.91M | Buy |
+23,047
| New | +$1.91M | 1.88% | 13 |
|
|
2015
Q3 | $1.18M | Sell |
11,155
-1,012
| -8% | -$107K | 3.27% | 20 |
|
|
2015
Q2 | $1.66M | Buy |
12,167
+2,452
| +25% | +$335K | 2.25% | 6 |
|
|
2015
Q1 | $1.21M | Buy |
+9,715
| New | +$1.21M | 2.29% | 3 |
|
|
2014
Q1 | – | Sell |
-100
| Closed | -$7K | – | 22 |
|
|
2013
Q4 | $7K | Hold |
100
| – | – | ﹤0.01% | 66 |
|
|
2013
Q3 | $7K | Hold |
100
| – | – | ﹤0.01% | 65 |
|
|
2013
Q2 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 73 |
|